Skip to main content
FDA Shortage Check

Is Lovenox (Enoxaparin Sodium Injection) being discontinued?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

DISCONTINUATION NOTICE

Lovenox: being discontinued (FDA, Oct 24)

Injections (vials)
A generic injection, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
DRUG
Lovenox
FDA LISTING
FORM
injection
STATUS
Discontinuation
FIRST POSTED
Oct 20, 2026
LAST FDA UPDATE
Oct 20, 2026
AS OF
Oct 24, 2026
SOURCE

2 discontinuation notices below, in FDA's words. A discontinuation “does not necessarily create a shortage” (FDA).

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Enoxaparin Sodium Injection. 24 presentations from 1 maker.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Discontinuation notices

A discontinuation “does not necessarily create a shortage” (FDA).

  • Sanofi-Aventis U.S. LLC told FDA it will discontinue Enoxaparin Sodium (posted ).

    “Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.”

    FDA listing: Enoxaparin Sodium Injection

  • Sanofi-Aventis U.S. LLC told FDA it will discontinue Lovenox (posted ).

    “Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.”

    FDA listing: Enoxaparin Sodium Injection

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Lovenox being discontinued?
As of Oct 24, 2026, FDA lists discontinuation notices for Enoxaparin Sodium Injection, not a shortage. A discontinuation “does not necessarily create a shortage” (FDA).
When will the Lovenox shortage end?
FDA gives no end date, and no manufacturer posted a recovery estimate for this listing.
Does FDA list alternatives to Lovenox?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.